SWAYZE ERIC (SVP, Research) sold 32.8% of their position (15.64K shares) of IONIS PHARMACEUTICALS INC on the open market
Open‑market sale worth $1.28M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/13/2026ACC: 0000874015-26-000111
Officer· SVP, Research
Since Jan 2020
-15.64K
Net shares
Net seller
$1.28M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
15.64K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−9.44K
Price / share
$81.56
Trade value
$769.51K
% of position
19.8%
2/13/2026
47.75K→38.31K
Common Stock
Direct
Shares
−6.21K
Price / share
$82.07
Trade value
$509.40K
% of position
16.2%
2/13/2026
38.31K→32.10K
Total
Net shares
−15.64K
Net value
-$1.28M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/13/2026 | S · Sale | −9.44K | $81.56 | $769.51K | 19.8% | 47.75K | 38.31K |
| Common Stock Direct | 2/13/2026 | S · Sale | −6.21K | $82.07 | $509.40K | 16.2% | 38.31K | 32.10K |
| Total | −15.64K | -$1.28M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned318.00
Total
318.00 indirect318.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 318.00 | Indirect |
| Total | 318.00 | 318.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported